ClinicaliQ Trial Snapshot
- RETHINK REFLUX Registry — Active Not Recruiting • Gastroenterology • NCT04253392.
- Long-term safety study tracking patients with surgically implanted LINX reflux devices for up to 10 years after implantation.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant. Conditions: Gastroesophageal Reflux Interventions: LINX Reflux Management System Lead Sponsor: Ethicon Endo-Surgery Planned Enrollment: 500 participants